Citation: R. Asbury et al., A PHASE-II TRIAL OF AMONAFIDE IN PATIENTS WITH MIXED MESODERMAL TUMORS OF THE UTERUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 21(3), 1998, pp. 306-307
Authors:
NDUBISI B
SANZ S
LU L
PODCZASKI E
BENRUBI G
MASOOD S
Citation: B. Ndubisi et al., THE PROGNOSTIC VALUE OF HER-2 NEU ONCOGENE IN CERVICAL-CANCER/, Annals of clinical and laboratory science, 27(6), 1997, pp. 396-401
Authors:
HACKETT TE
OLT G
SOROSKY JI
PODCZASKI E
HARRISON TA
MORTEL R
Citation: Te. Hackett et al., SURGICAL PREDICTORS OF PARAAORTIC METASTASES IN EARLY-STAGE CERVICAL-CARCINOMA, Gynecologic oncology, 59(1), 1995, pp. 15-19
Authors:
HACKETT TE
KAMINSKI P
OLT GJ
ZAINO R
PODCZASKI E
Citation: Te. Hackett et al., TISSUE DISTRIBUTION OF TAG-72 IN MALIGNANT MIXED MULLERIAN TUMORS OF THE UTERUS, Gynecologic oncology, 52(2), 1994, pp. 165-171
Authors:
PODCZASKI E
KAMINSKI P
HACKETT TE
OLT GJ
ZAINO R
Citation: E. Podczaski et al., TISSUE CA-125 AND CA-19-9 IN MALIGNANT, MIXED MESODERMAL TUMORS OF THE UTERUS, Gynecologic oncology, 49(1), 1993, pp. 56-60